158 related articles for article (PubMed ID: 33622576)
1. Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bone: A retrospective analysis of available scoring tools.
Righi A; Pacheco M; Palmerini E; Carretta E; Gambarotti M; Longhi A; Magagnoli G; Sbaraglia M; Manfrini M; Picci P; Dei Tos AP
Eur J Surg Oncol; 2021 Jul; 47(7):1778-1783. PubMed ID: 33622576
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma.
Bacci G; Picci P; Mercuri M; Ferrari S; Longhi A; Cesari M; Rosito P; Mancini AF; Barbieri E; Baldini N
Acta Oncol; 1998; 37(7-8):671-6. PubMed ID: 10050985
[TBL] [Abstract][Full Text] [Related]
3. Different
El-Hennawy G; Moustafa H; Omar W; Elkinaai N; Kamel A; Zaki I; Farid N; El-Kholy E
Pediatr Blood Cancer; 2020 Nov; 67(11):e28605. PubMed ID: 32706520
[TBL] [Abstract][Full Text] [Related]
4. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases.
Hoffmann C; Ahrens S; Dunst J; Hillmann A; Winkelmann W; Craft A; Göbel U; Rübe C; Voute PA; Harms D; Jürgens H
Cancer; 1999 Feb; 85(4):869-77. PubMed ID: 10091764
[TBL] [Abstract][Full Text] [Related]
5. The role of surgery and resection margins in the treatment of Ewing's sarcoma.
Sluga M; Windhager R; Lang S; Heinzl H; Krepler P; Mittermayer F; Dominkus M; Zoubek A; Kotz R
Clin Orthop Relat Res; 2001 Nov; (392):394-9. PubMed ID: 11716413
[TBL] [Abstract][Full Text] [Related]
6. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.
Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ
Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities.
Picci P; Rougraff BT; Bacci G; Neff JR; Sangiorgi L; Cazzola A; Baldini N; Ferrari S; Mercuri M; Ruggieri P
J Clin Oncol; 1993 Sep; 11(9):1763-9. PubMed ID: 8355043
[TBL] [Abstract][Full Text] [Related]
8. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.
Wunder JS; Paulian G; Huvos AG; Heller G; Meyers PA; Healey JH
J Bone Joint Surg Am; 1998 Jul; 80(7):1020-33. PubMed ID: 9698007
[TBL] [Abstract][Full Text] [Related]
9. Curettage, phenolization, and cementation in paediatric Ewing's sarcoma with a complete radiological response to neoadjuvant chemotherapy.
Jamshidi K; Ramezan Shirazi M; Bagherifard A; Mirzaei A
Int Orthop; 2019 Feb; 43(2):467-473. PubMed ID: 30099643
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy.
Delepine N; Delepine G; Cornille H; Voisin MC; Brun B; Desbois JC
J Chemother; 1997 Oct; 9(5):352-63. PubMed ID: 9373791
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
[TBL] [Abstract][Full Text] [Related]
13. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
[TBL] [Abstract][Full Text] [Related]
14. [Pediatric Ewing sarcoma of the rib: role of neoadjuvant chemotherapy in tumoral shrinking and sterilization. A case report].
Zidane A; Traibi A; Arsalane A; Atoini F; Ouriachi F; Hammoumi M; Kabiri EH
Rev Pneumol Clin; 2011 Dec; 67(6):371-4. PubMed ID: 22137283
[TBL] [Abstract][Full Text] [Related]
15. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
[TBL] [Abstract][Full Text] [Related]
16. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R
J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992.
Bacci G; Forni C; Longhi A; Ferrari S; Donati D; De Paolis M; Barbieri E; Pignotti E; Rosito P; Versari M
Eur J Cancer; 2004 Jan; 40(1):73-83. PubMed ID: 14687792
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the management of localized Ewing sarcoma in a developing country.
Totadri S; Bansal D; Rao KLN; Jain R; Saxena AK; Kapoor R; Samujh R; Trehan A
Pediatr Hematol Oncol; 2020 Oct; 37(7):610-619. PubMed ID: 32558608
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different.
Gaston LL; Di Bella C; Slavin J; Hicks RJ; Choong PF
Skeletal Radiol; 2011 Aug; 40(8):1007-15. PubMed ID: 21298431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
